QCM
NUVB icon

Quantinno Capital Management’s Nuvation Bio NUVB Stock Holding History

Quantinno Capital Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$597K Buy
139,257
+98,158
+239% +$547K ﹤0.01% 2581
2025
Q4 		$368K Buy
+41,099
New +$255K ﹤0.01% 2695

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Quantinno Capital Management's NUVB Position: Q1 2026 in Review

Quantinno Capital Management increased its Nuvation Bio (NUVB) stake by 239% in Q1 2026, buying an estimated $547K and bringing the position to 139,257 shares worth $597K. The position accounts for ﹤0.01% of the portfolio, ranked #2581.

Quantinno Capital Management first reported a position in NUVB in Q4 2025 and has held it in 2 quarters since. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Quantinno Capital Management held 139,257 shares of Nuvation Bio worth $597K as of Q1 2026.
  • Quantinno Capital Management bought 98,158 Nuvation Bio shares in Q1 2026, an estimated $547K.
  • Nuvation Bio made up ﹤0.01% of Quantinno Capital Management's portfolio in Q1 2026, its #2581 holding.
  • Quantinno Capital Management first reported a position in Nuvation Bio in Q4 2025 and has held it in 2 quarters since.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.